Based in Cambridge, MA and Berlin, Germany, Cytolon is a digital health company introducing a unique product offering into an exciting new area: patient empowerment in the context of clinical trials.
Cytolon is an incubator for patient empowerment providing tangible benefit to patients, clinicians and industry alike. Our unique subscription-based software as a service platform will build a new level of transparency and trust across the pharmaceutical industry while providing insight into long-term health trends and treatment efficacy.
Our Commitment to Excellence
- Establish a unique partnership between patients, investigators, and pharma
- Grant users access to unique services, e.g. opt-in for personalized services whilst keeping privacy protected
- On-going patient engagement before, during, and after clinical trial, e.g. by returning personal healthcare data and providing patient-friendly trial summaries
- Collect and manage patient data, e.g. by sharing personal healthcare data with friends and family or even donating personal data to research
Software As A Service
Patients As Partners
Our proprietary patent-pending interplay of data return with other digital services will drive the future of patients and their caregivers as partners with industry in research and development.
Working With the Best
Cytolon is engaged with top-tier pharmaceutical companies to pilot on the final product design. The Cytolon Patient Engagement Platform will be launched in 2015 offering a subscription-based software as a service model to pharmaceutical industry.
Get in Touch with Cytolon!
Sign-up to receive updates on our progress and to be the first to know when we launch!
United States Office
One Broadway, 14th Floor
Cambridge, MA 02142
United States of America
Am Karlsbad 15
10785 Berlin, Germany